Approved in asthma and chronic obstructive pulmonary disease (COPD), Advair is a combination of the long-acting beta agonist salmeterol and the corticosteroid fluticasone and is still a ...

Patients should rinse the mouth after inhalation of Advair HFA. Orally inhaled corticosteroids may cause a reduction in growth velocity when administered to pediatric patients. Monitor the growth ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...

The main patent on Advair (fluticasone+salmeterol ... whose disease warrants initiation of treatment with both inhaled corticosteroids and long-acting beta agonists. It is also approved for ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ... the dose of their inhaled corticosteroid medication ...